Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Daiichi Sankyo receives additional indication approval in Japan for Ranmark

May 27, 2014

EMA committee recommends approval of obinutuzumab

May 26, 2014

GSK and Genmab report topline data from pivotal head-to-head study of ofatumumab

May 21, 2014

MOR-208 receives FDA and EMA orphan drug designations

May 21, 2014

ADC Therapeutics and MedImmune to advance ADCT-401 into clinic

May 21, 2014

NeoStem signs licensing agreement with Cellular Biomedicine for DC-TC

May 20, 2014

Helix BioPharma seeks Canadian clearance for study of L-DOS47

May 15, 2014

FDA grants nivolumab breakthrough therapy designation for Hodgkin's lymphoma

May 15, 2014

FDA grants fast track status to Prima BioMed's CVac program

May 12, 2014

Cellmid selects lead anti-MK antibody in oncology

May 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...